Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × epoetin beta × Clear all

Phase

Status

Sponsor Class

INDUSTRY 8 NIH 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Cyclophosphamide 1780 Radiotherapy 1645 Cisplatin 1570 Carboplatin 1338 Gemcitabine 1242 Paclitaxel 1134 Bevacizumab 1100 Docetaxel 1066 pembrolizumab 1047 Oxaliplatin 1017 Capecitabine 1014 Fluorouracil 954 Dexamethasone 853 Rituximab 806 Nivolumab 798 Magnetic Resonance Spectroscopy 749 Etoposide 732 Doxorubicin 717 Irinotecan 683 Drug Therapy 675 Radiosurgery 673 Cytarabine 648 fludarabine 629 Leucovorin 605 Lenalidomide 542 fludarabine phosphate 494 Temozolomide 485 Radiation 483 Filgrastim 475 Cetuximab 469

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡